Glucagon-like peptide-1
While GLP-1 drugs are capturing headlines, they aren't the only medications approved for weight loss
People already dealing with bloating from GLP-1 medications should approach this supplement with particular caution, as the effects can stack
GLP-1 and GIP-based therapies may be appropriate for individuals with Type 2 diabetes, insulin resistance, or those who are overweight (BMI 2730+) with at least one weight-related condition such as high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease
Thus, the rising geriatric population prone to diabetes across Asia Pacific would propel the demand for effective treatments such as GLP-1 analogues during the forecast period
Others say they become scent-sensitive only during specific periods, such as dose escalations or post-injection windows